In a step that can ensure earlier detection and treatment of breast cancer and help improve survival rates, British researchers have developed an "ultra-sensitive" new blood test which can predict if the cancer will return years .
'Ultra-sensitive' cancer blood test is highly accurate in identifying which breast cancer patients will relapse The 'Personalis NeXT Personal® liquid biopsy' test uses whole genome sequencing